Ultragenyx
RARE
$44.24
Share price
0.89%
Change (1 day)
4.19%
Change (1 year)
Categories
Ultragenyx (RARE) - Total debt
Total debt on the balance sheet as of December 2023 : $43.16 M
According to Ultragenyx's latest financial reports the company's total debt is $43.16 M. A company’s total debt is the sum of all current and non-current debts.
Ultragenyx - Total debt on balance sheet (from 2018 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $43.16 M | 36.64% |
| 2022-12-31 | $31.59 M | -24.72% |
| 2021-12-31 | $41.97 M | -12.97% |
| 2020-12-31 | $48.22 M | 30.37% |
| 2019-12-31 | $36.99 M | |
| 2018-12-31 | $N/A |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | $0.10 B | 145.54% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $0.26 B | 516.57% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $0.44 B | 930.97% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.09 B | 2,438.28% | 🇺🇸 USA |